US Stock MarketDetailed Quotes

ZVSA ZyVersa Therapeutics

Watchlist

5.2500
+0.3713+7.61%

Close Jun 14 16:00 ET

5.3500
+0.1000+1.90%

Post 19:58 ET

4.38MMarket Cap-5P/E (TTM)

ZyVersa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 12, 2022

(Q4)Dec 12, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

17.71%-3.78M

-483.47%-8.72M

-569.54%-2.79M

-140.80%-936.39K

-29.19%-407.62K

-1,127.29%-4.59M

70.56%-1.49M

32.44%-416.31K

44.32%-388.86K

-315.52K

Net income from continuing operations

20.24%-2.83M

-599.75%-98.3M

-189.82%-13.34M

21.40%-2.9M

-3,817.40%-78.51M

5.46%-3.54M

-73.77%-14.05M

-133.72%-4.6M

-96.43%-3.69M

---2M

Operating gains losses

----

237.46%607K

1,627.88%186.4K

149.59%228.1K

---19.6K

Depreciation and amortization

0.00%2.6K

5.39%10.4K

25.73%2.6K

0.00%2.6K

-5.12%9.87K

-20.46%2.07K

0.00%2.6K

--2.6K

Deferred tax

--0

---9.48M

---596.07K

---485

---7.84M

---1.05M

--0

Other non cash items

-79.14%87.04K

1,507.01%1.92M

12.19%89.66K

159.33%22.82K

5,414.69%1.39M

690.78%417.25K

-62.43%119.41K

21.28%79.92K

-144.27%-38.46K

--25.19K

Change In working capital

-78.97%-1.26M

-68.64%2.6M

-139.72%-1.4M

-35.13%1.7M

205.53%3.01M

-160.56%-705.76K

912.68%8.29M

642.30%3.52M

1,604.21%2.62M

--984.56K

-Change in prepaid assets

40.61%-651.02K

-41.37%193.07K

-50.33%112.58K

-49.82%460.39K

257.60%716.3K

-204.19%-1.1M

210.84%329.3K

840.05%226.67K

2,821.28%917.49K

---454.49K

-Change in payables and accrued expense

-245.50%-603.4K

-68.85%2.51M

-143.94%-1.49M

-23.71%1.26M

58.50%2.32M

-73.21%414.69K

1,212.90%8.05M

569.51%3.38M

1,254.84%1.66M

--1.46M

-Change in other current liabilities

64.30%-8.66K

-16.26%-100.1K

70.16%-25.69K

-156.64%-25.28K

-10.10%-24.88K

-10.09%-24.25K

---86.1K

--44.63K

---22.6K

Cash from discontinued investing activities

Operating cash flow

17.71%-3.78M

-483.47%-8.72M

-569.54%-2.79M

-140.80%-936.4K

-29.19%-407.62K

-1,127.29%-4.59M

70.56%-1.49M

32.44%-416.31K

44.32%-388.86K

---315.52K

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Financing cash flow

Cash flow from continuing financing activities

7,807.50%2.67M

219.31%5.96M

747.43%4.35M

244.96%2.29M

-316.52%-641.76K

-108.82%-34.67K

-64.33%1.87M

512.88K

662.8K

296.4K

Net common stock issuance

----

--18.11M

--5M

--2.1M

----

--0

----

Net preferred stock issuance

----

-644.44%-10.7M

-100.00%-1

-123.08%-230K

----

--1.96M

--548.8K

--996.4K

--1

Proceeds from stock option exercised by employees

--2.67M

--967.48K

--179

3,638.79%972.8K

---5.5K

--0

--26.02K

----

Net other financing activities

----

-2,343.61%-2.42M

-1,719.30%-653.51K

-54.45%-555.43K

-465.67%-1.18M

-33.26%-34.67K

---99.14K

---35.92K

---359.62K

--322.42K

Cash from discontinued financing activities

Financing cash flow

7,807.50%2.67M

219.31%5.96M

747.43%4.35M

244.96%2.29M

-316.52%-641.76K

-108.82%-34.67K

-64.33%1.87M

--512.88K

--662.8K

--296.4K

Net cash flow

Beginning cash position

-46.84%3.14M

1,696.27%5.9M

161.92%1.58M

-30.45%228.69K

267.34%1.28M

1,696.27%5.9M

88.12%328.58K

-36.20%602.75K

-79.99%328.82K

--347.93K

Current changes in cash

76.12%-1.1M

-845.67%-2.76M

1,514.27%1.56M

392.83%1.35M

-5,389.54%-1.05M

-23,997.29%-4.62M

140.88%370.74K

115.67%96.57K

139.23%273.94K

---19.12K

End cash Position

59.11%2.03M

348.67%3.14M

161.92%1.58M

-30.45%228.69K

267.34%1.28M

112.83%699.32K

-36.20%602.75K

--328.82K

Free cash flow

17.71%-3.78M

-483.47%-8.72M

-569.54%-2.79M

-140.80%-936.4K

-29.19%-407.62K

-1,127.29%-4.59M

70.56%-1.49M

32.44%-416.31K

44.32%-388.86K

---315.52K

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 12, 2022	(Q4)Dec 12, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	17.71%-3.78M	-483.47%-8.72M	-569.54%-2.79M	-140.80%-936.39K	-29.19%-407.62K	-1,127.29%-4.59M	70.56%-1.49M	32.44%-416.31K	44.32%-388.86K	-315.52K
Net income from continuing operations	20.24%-2.83M	-599.75%-98.3M	-189.82%-13.34M	21.40%-2.9M	-3,817.40%-78.51M	5.46%-3.54M	-73.77%-14.05M	-133.72%-4.6M	-96.43%-3.69M	---2M
Operating gains losses	----	----	----	----	----	----	237.46%607K	1,627.88%186.4K	149.59%228.1K	---19.6K
Depreciation and amortization	0.00%2.6K	5.39%10.4K	25.73%2.6K	0.00%2.6K	0.00%2.6K	0.00%2.6K	-5.12%9.87K	-20.46%2.07K	0.00%2.6K	--2.6K
Deferred tax	--0	---9.48M	---596.07K	---485	---7.84M	---1.05M	--0	--0	--0	--0
Other non cash items	-79.14%87.04K	1,507.01%1.92M	12.19%89.66K	159.33%22.82K	5,414.69%1.39M	690.78%417.25K	-62.43%119.41K	21.28%79.92K	-144.27%-38.46K	--25.19K
Change In working capital	-78.97%-1.26M	-68.64%2.6M	-139.72%-1.4M	-35.13%1.7M	205.53%3.01M	-160.56%-705.76K	912.68%8.29M	642.30%3.52M	1,604.21%2.62M	--984.56K
-Change in prepaid assets	40.61%-651.02K	-41.37%193.07K	-50.33%112.58K	-49.82%460.39K	257.60%716.3K	-204.19%-1.1M	210.84%329.3K	840.05%226.67K	2,821.28%917.49K	---454.49K
-Change in payables and accrued expense	-245.50%-603.4K	-68.85%2.51M	-143.94%-1.49M	-23.71%1.26M	58.50%2.32M	-73.21%414.69K	1,212.90%8.05M	569.51%3.38M	1,254.84%1.66M	--1.46M
-Change in other current liabilities	64.30%-8.66K	-16.26%-100.1K	70.16%-25.69K	-156.64%-25.28K	-10.10%-24.88K	-10.09%-24.25K	---86.1K	---86.1K	--44.63K	---22.6K
Cash from discontinued investing activities
Operating cash flow	17.71%-3.78M	-483.47%-8.72M	-569.54%-2.79M	-140.80%-936.4K	-29.19%-407.62K	-1,127.29%-4.59M	70.56%-1.49M	32.44%-416.31K	44.32%-388.86K	---315.52K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities	7,807.50%2.67M	219.31%5.96M	747.43%4.35M	244.96%2.29M	-316.52%-641.76K	-108.82%-34.67K	-64.33%1.87M	512.88K	662.8K	296.4K
Net common stock issuance	----	--18.11M	--5M	--2.1M	----	----	--0	--0	--0	----
Net preferred stock issuance	----	-644.44%-10.7M	-100.00%-1	-123.08%-230K	----	----	--1.96M	--548.8K	--996.4K	--1
Proceeds from stock option exercised by employees	--2.67M	--967.48K	--179	3,638.79%972.8K	---5.5K	--0	--0	--0	--26.02K	----
Net other financing activities	----	-2,343.61%-2.42M	-1,719.30%-653.51K	-54.45%-555.43K	-465.67%-1.18M	-33.26%-34.67K	---99.14K	---35.92K	---359.62K	--322.42K
Cash from discontinued financing activities
Financing cash flow	7,807.50%2.67M	219.31%5.96M	747.43%4.35M	244.96%2.29M	-316.52%-641.76K	-108.82%-34.67K	-64.33%1.87M	--512.88K	--662.8K	--296.4K
Net cash flow
Beginning cash position	-46.84%3.14M	1,696.27%5.9M	161.92%1.58M	-30.45%228.69K	267.34%1.28M	1,696.27%5.9M	88.12%328.58K	-36.20%602.75K	-79.99%328.82K	--347.93K
Current changes in cash	76.12%-1.1M	-845.67%-2.76M	1,514.27%1.56M	392.83%1.35M	-5,389.54%-1.05M	-23,997.29%-4.62M	140.88%370.74K	115.67%96.57K	139.23%273.94K	---19.12K
End cash Position	59.11%2.03M	348.67%3.14M	348.67%3.14M	161.92%1.58M	-30.45%228.69K	267.34%1.28M	112.83%699.32K	112.83%699.32K	-36.20%602.75K	--328.82K
Free cash flow	17.71%-3.78M	-483.47%-8.72M	-569.54%-2.79M	-140.80%-936.4K	-29.19%-407.62K	-1,127.29%-4.59M	70.56%-1.49M	32.44%-416.31K	44.32%-388.86K	---315.52K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall